4//SEC Filing
Bolorforosh Said 4
Accession 0001127602-19-021563
CIK 0000313143other
Filed
Jun 12, 8:00 PM ET
Accepted
Jun 13, 4:33 PM ET
Size
4.9 KB
Accession
0001127602-19-021563
Insider Transaction Report
Form 4
Bolorforosh Said
EVP, Chief Technology Officer
Transactions
- Sale
Common Stock
2019-06-12$109.37/sh−69$7,547→ 2,141 total
Footnotes (2)
- [F1]Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of certain restricted stock units previously reported in Table I following the date of grant. This sale is mandated by the Issuer's election under its 2005 Long Term Incentive Compensation Plan (as amended) to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person.
- [F2]This number includes unvested restricted stock units previously reported.
Documents
Issuer
HAEMONETICS CORP
CIK 0000313143
Entity typeother
Related Parties
1- filerCIK 0001741776
Filing Metadata
- Form type
- 4
- Filed
- Jun 12, 8:00 PM ET
- Accepted
- Jun 13, 4:33 PM ET
- Size
- 4.9 KB